WORK Medical Technology Group Ltd.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Shuang Wu
- Full Time Employees
- 216
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- No. 2 Tonghuinan Road Hangzhou City People's Republic of China
- IPO Date
- Aug 23, 2024
- CIK
- 0001929783
- Website
- hzsy120.com
- Similar Companies
- Business
- WORK Medical Technology Group Ltd (Nasdaq: WOK) manufactures and sells Class I and II disposable medical consumables and devices through its subsidiaries primarily in the People's Republic of China. The company offers an extensive range of products including medical face masks; artery compression tourniquets; endotracheal tube holders; intubating stylets; guedel airways; disposable breathing circuits; laryngeal mask airways; endotracheal tubes; anesthetic kits; oxygen face masks; heat and moisture exchanging filters; anesthesia masks; laryngoscope blades; suction sets; nasal oxygen cannulas; KN95 masks; filtering half masks; and visualized prostatic dilatation catheters. These products serve hospitals, pharmacies, medical institutions, and distributors domestically across 34 provincial-level administrative regions in China and are exported to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. Founded in 2002 and headquartered in Hangzhou City, Zhejiang Province, China, the company listed on Nasdaq in August 2024. Recent developments include a strategic partnership in February 2025 with Shanghai Chartwell Medical Device Co., Ltd. to explore joint investment funds, potential mergers, healthcare infrastructure projects, advanced technology R&D, and global acquisitions; a September 2025 collaboration with the Wuxi Branch of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine to develop AI-driven smart clinical ecosystems and multimodal AI solutions; a September 2025 partnership with the Hong Kong Web3.0 Standardization Association to advance blockchain, asset tokenization, equity investments, and real-world asset (RWA) innovations; a US$1 million investment in October 2025 for a 10% stake in Neologics Bioscience to support its R&D and expansion with governance rights; a US$114,000 service contract secured by its subsidiary in November 2025 from GemPharmatech Corporation; and a 1-for-100 reverse stock split effective October 21, 2025, alongside Nasdaq compliance extensions.
WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model
WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model
WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper
WORK Medical Technology Group (NASDAQ:WOK) Shares Down 10.8% – Time to Sell?
Critical Survey: TransMedics Group (NASDAQ:TMDX) vs. WORK Medical Technology Group (NASDAQ:WOK)
WORK Medical Technology Group (NASDAQ:WOK) Stock Price Down 3.5% – What’s Next?
Orthofix Medical (NASDAQ:OFIX) vs. WORK Medical Technology Group (NASDAQ:WOK) Financial Contrast
WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026
WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025
WORK Medical Technology Group LTD's Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation
WORK Medical Technology Group LTD Announces US$1 Million Equity Investment in Neologics Bioscience
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025
WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq
WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance
Univest Securities, LLC Announces Closing of $2.9 Million Registered Direct Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)
WORK Medical Technology Group LTD Announces Pricing of $2.9 Million Registered Direct Offering
WORK Medical To Explore RWA Initiatives Via Partnerships
WORK Medical Technology Group LTD Partners with Wuxi Branch of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine to Develop AI-Applications in Healthcare
Univest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)